Showing results 30 to 30 of 30
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
When compared to plasma‐based detection, osimertinib‐treated non‐small cell lung cancer (NSCLC) with tissue rebiopsy‐confirmed acquired T790M mutation is associated with better survival Journal:Asia-Pacific Journal of Clinical Oncology | 2021 |